Search Results - "Torbicki, Adam"

Effect of Macitentan in Pulmonary Arterial Hypertension and the Relationship Between Echocardiography and cMRI Variables: REPAIR Echocardiography Sub-study Results.

Authors: Torbicki, Adam Channick, Richard Galiè, Nazzareno et al.

Source: Cardiology & Therapy. Mar2024, Vol. 13 Issue 1, p173-190. 18p.

Validation Analysis of the Polish-Translated Version of EmPHasis-10 Health-Related Quality of Life Questionnaire in Patients with Pulmonary Arterial Hypertension.

Authors: Wieteska-Miłek, Maria Tkaczyk, Dominika Torbicki, Adam et al.

Source: Journal of Clinical Medicine. Mar2026, Vol. 15 Issue 5, p2020. 12p.

Precision medicine: The future of diagnostic approach to pulmonary hypertension?

Authors: Kedzierski, Piotr Torbicki, Adam

Source: Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi. Oct2019, Vol. 22 Issue 4, p168-171. 4p.

The Diagnostic Approach to Pulmonary Hypertension.

Authors: Torbicki, Adam Kurzyna, Marcin

Source: Seminars in Respiratory & Critical Care Medicine. Dec2023, Vol. 44 Issue 6, p728-737. 10p.

Ghidul european de diagnostic şi tratament al emboliei pulmonare acute (versiunea 2014).

Alternate Title: 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism.

Authors: Konstantinides, Stavros V. Torbicki, Adam Agnelli, Giancarlo et al.

Source: Romanian Journal of Cardiology. 2015, Vol. 25 Issue 1, p75-133. 59p.

Rate Control vs Rhythm Control in Patients With Nonvalvular Persistent Atrial Fibrillation.

Authors: Opolski, Grzegorz Torbicki, Adam Kosior, Dariusz A. et al.

Source: CHEST. Aug2004, Vol. 126 Issue 2, p476-486. 11p.

EFFECT OF MACITENTAN ON CARDIAC FUNCTION IN PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM THE REPAIR ECHOCARDIOGRAPHY SUBSTUDY.

Authors: Torbicki, Adam Channick, Richard Cottreel, Emmanuelle et al.

Source: CHEST. 2020 Supplement, Vol. 158, pA2224-A2227. 4p.

The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil.

Authors: Jansa, Pavel Kopeć, Grzegorz Torbicki, Adam et al.

Source: Pulmonary Circulation. Jul2023, Vol. 13 Issue 3, p1-10. 10p.

Pulmonary Hypertension: Diagnosis and Management.

Authors: Torbicki, Adam¹ (AUTHOR) adam.torbicki@ecz-otwock.pl

Source: Diagnostics (2075-4418). Jun2021, Vol. 11 Issue 6, p1066-1066. 1p.

Milestones in Understanding Pulmonary Circulation: From Antiquity to Heart-Lung Machine.

Authors: Torbicki, Adam Grenier, Philippe A.

Source: Diagnostics (2075-4418). Feb2021, Vol. 11 Issue 2, p381-381. 1p.

The Challenge to Decide between Pulmonary Hypertension Due to Chronic Lung Disease and PAH with Chronic Lung Disease.

Authors: Olschewski, Horst Torbicki, Adam

Source: Diagnostics (2075-4418). Feb2021, Vol. 11 Issue 2, p311-311. 1p.

Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension

Authors: Sandoval, Julio Torbicki, Adam Souza, Rogerio et al.

Source: Pulmonary Pharmacology & Therapeutics. Feb2012, Vol. 25 Issue 1, p33-39. 7p.

Acute and long term management of pulmonary embolism.

Authors: Torbicki, Adam¹ a.torbicki@gichp.edu.pl

Source: Heart. Sep2010, Vol. 96 Issue 17, p1418-1424. 7p.

Right heart thrombi in pulmonary embolism: Results from the international cooperative pulmonary embolism registry

Authors: Torbicki, Adam Galié, Nazzareno Covezzoli, Anna et al.

Source: Journal of the American College of Cardiology (JACC). Jun2003, Vol. 41 Issue 12, p2245. 7p.

Disturbed right ventricular ejection pattern as a new Doppler echocardiographic sign of acute pulmonary embolism

Authors: Kurzyna, Marcin Torbicki, Adam Pruszczyk, Piotr et al.

Source: American Journal of Cardiology. Sep2002, Vol. 90 Issue 5, p507-511. 5p.

Sex-Specific Differences in Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.

Authors: Kurzyna, Paweł Witowicz, Anna Kędzierski, Piotr et al.

Source: Journal of Clinical Medicine. Feb2025, Vol. 14 Issue 3, p899. 16p.

‘Syringe-in-the-Pocket’ – A New Approach to the Outpatient Thromboembolic Prophylaxis of Recurrent Atrial Fibrillation.

Authors: Kosior, Dariusz A. Torbicki, Adam Opolski, Grzegorz

Source: Cardiology. 2007, Vol. 107 Issue 4, p370-372. 3p.

Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities.

Authors: McLaughlin, Vallerie V. Sitbon, Olivier Chin, Kelly M. et al.

Source: European Journal of Heart Failure. Nov2024, Vol. 26 Issue 11, p2379-2391. 13p.

Impact of Elevated Pulmonary Arterial Wedge Pressure on Safety and Efficacy of Balloon Pulmonary Angioplasty in the Treatment of Chronic Thromboembolic Pulmonary Hypertension.

Authors: Szwed, Piotr Kurzyna, Paweł Banaszkiewicz, Marta et al.

Source: CHEST. Feb2026, Vol. 169 Issue 2, p498-508. 11p.

Myo‐inositol trispyrophosphate prevents right ventricular failure and improves survival in monocrotaline‐induced pulmonary hypertension in the rat.

Authors: Oknińska, Marta Paterek, Aleksandra Grzanka, Małgorzata et al.

Source: British Journal of Pharmacology. Oct2024, Vol. 181 Issue 20, p4050-4066. 17p.